ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
Higher IGF-1 Predicted Higher Mortality
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="stx359" data-source="post: 179807" data-attributes="member: 19129"><p>Also the data shown in figure one demonstrate that their own data does not support the conclusion that "In conclusion, higher IGF-1 levels and bioavailability predicted mortality and morbidity risk."</p><p></p><p>For the non statisticians on the board when the lines on either side of the data point, known as error bars, cross the 1.0 point on the hazard ratio axis that means that statistically the two groups are not different. This was the case for three out of four study measurements. The only measurement that showed a mortality difference was IGF-1/IGFBP-3 ratio and when they broke down the study group to males and females this only appeared to be true for females. In males there was no mortality difference in any of the study measurements.</p></blockquote><p></p>
[QUOTE="stx359, post: 179807, member: 19129"] Also the data shown in figure one demonstrate that their own data does not support the conclusion that "In conclusion, higher IGF-1 levels and bioavailability predicted mortality and morbidity risk." For the non statisticians on the board when the lines on either side of the data point, known as error bars, cross the 1.0 point on the hazard ratio axis that means that statistically the two groups are not different. This was the case for three out of four study measurements. The only measurement that showed a mortality difference was IGF-1/IGFBP-3 ratio and when they broke down the study group to males and females this only appeared to be true for females. In males there was no mortality difference in any of the study measurements. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
Higher IGF-1 Predicted Higher Mortality
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top